METTL3 and neoplasm: This CAF–METTL3–RAC3 axis significantly promotes cancer cell metastasis and tumor growth, with METTL3 overexpression correlating with poor patient prognosis, highlighting its potential as a therapeutic target for metastatic lung cancer [240].